Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Nishiyama

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Urology|November 11, 2005
Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tractEiji Kikuchi, Yutaka Horiguchi, Jun Nakashima, et al.
Brachytherapy|April 24, 2022
Secondary bladder cancer during long-term follow-up after iodine-125 permanent seed implantation for localized prostate cancerYu Ozawa, Yasuto Yagi, Ken Nakamura, et al.
Journal of Contemporary Brachytherapy|August 23, 2019
Whole-gland salvage treatment for recurrent prostate cancer after initial definitive radiotherapy: A case series of <sup>125</sup>I brachytherapy and robot-assisted radical prostatectomyShinya Sutani, Atsunori Yorozu, Kazuhito Toya, et al.
Clinical Genitourinary Cancer|May 30, 2016
Are the Formulas Used to Estimate Renal Function Adequate for Patients Treated With Cisplatin-Based Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Carcinoma?Naoya Niwa, Eiji Kikuchi, Matsushima Masashi, et al.
Human Cell|August 1, 2008
Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatmentsYutaka Horiguchi, Eiji Kikuchi, Choichiro Ozu, et al.
Radiation Oncology (London, England)|January 10, 2014
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancerToshio Ohashi, Atsunori Yorozu, Shiro Saito, et al.
Brachytherapy|October 18, 2020
Effect of adding androgen deprivation therapy to permanent iodine-125 implantation with or without external beam radiation therapy on the outcomes in patients with intermediate-risk prostate cancer: A propensity score-matched analysisShinya Sutani, Atsunori Yorozu, Kazuhito Toya, et al.
Brachytherapy|September 25, 2018
Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapyNaoya Niwa, Kazuhiro Matsumoto, Toru Nishiyama, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2014
A dose-response analysis of biochemical control outcomes after (125)I monotherapy for patients with favorable-risk prostate cancerYutaka Shiraishi, Atsunori Yorozu, Toshio Ohashi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2013
Outcomes following iodine-125 prostate brachytherapy with or without neoadjuvant androgen deprivationToshio Ohashi, Atsunori Yorozu, Shiro Saito, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Urology|November 11, 2005
Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tractEiji Kikuchi, Yutaka Horiguchi, Jun Nakashima, et al.
Brachytherapy|April 24, 2022
Secondary bladder cancer during long-term follow-up after iodine-125 permanent seed implantation for localized prostate cancerYu Ozawa, Yasuto Yagi, Ken Nakamura, et al.
Journal of Contemporary Brachytherapy|August 23, 2019
Whole-gland salvage treatment for recurrent prostate cancer after initial definitive radiotherapy: A case series of <sup>125</sup>I brachytherapy and robot-assisted radical prostatectomyShinya Sutani, Atsunori Yorozu, Kazuhito Toya, et al.
Clinical Genitourinary Cancer|May 30, 2016
Are the Formulas Used to Estimate Renal Function Adequate for Patients Treated With Cisplatin-Based Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Carcinoma?Naoya Niwa, Eiji Kikuchi, Matsushima Masashi, et al.
Human Cell|August 1, 2008
Establishment of orthotopic mouse superficial bladder tumor model for studies on intravesical treatmentsYutaka Horiguchi, Eiji Kikuchi, Choichiro Ozu, et al.
Radiation Oncology (London, England)|January 10, 2014
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancerToshio Ohashi, Atsunori Yorozu, Shiro Saito, et al.
Brachytherapy|October 18, 2020
Effect of adding androgen deprivation therapy to permanent iodine-125 implantation with or without external beam radiation therapy on the outcomes in patients with intermediate-risk prostate cancer: A propensity score-matched analysisShinya Sutani, Atsunori Yorozu, Kazuhito Toya, et al.
Brachytherapy|September 25, 2018
Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapyNaoya Niwa, Kazuhiro Matsumoto, Toru Nishiyama, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2014
A dose-response analysis of biochemical control outcomes after (125)I monotherapy for patients with favorable-risk prostate cancerYutaka Shiraishi, Atsunori Yorozu, Toshio Ohashi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2013
Outcomes following iodine-125 prostate brachytherapy with or without neoadjuvant androgen deprivationToshio Ohashi, Atsunori Yorozu, Shiro Saito, et al.
Pageof 4